Loading...

Summit Therapeutics Inc.

SMMTNASDAQ
Healthcare
Biotechnology
$21.27
$0.35(1.67%)

Summit Therapeutics Inc. SMMT Peers

See (SMMT) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SMMT$21.27+1.67%15.8B-62.74-$0.34N/A
VRTX$442.58-1.71%114.5B-116.10-$3.84N/A
REGN$515.57-1.28%55.2B13.22$39.35+0.17%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$319.76-1.61%42B-152.52-$2.11N/A
ARGX$561.01-1.24%34.2B34.22$16.39N/A
BNTX$105.51+0.40%25.2B-28.60-$3.66N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$35.73-1.15%20.2B14.66$2.45+2.40%
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SMMT vs VRTX Comparison

SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMMT stands at 15.8B. In comparison, VRTX has a market cap of 114.5B. Regarding current trading prices, SMMT is priced at $21.27, while VRTX trades at $442.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMMT currently has a P/E ratio of -62.74, whereas VRTX's P/E ratio is -116.10. In terms of profitability, SMMT's ROE is -0.70%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, SMMT is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.

Stock Price Comparison

Loading...

Frequently Asked Questions

;